Diclofenac Sodium Prices, Trends & Forecast: Q2 2026 Market Analysis
According to ChemAnalyst , The global Diclofenac Sodium Prices moved lower during the second quarter of 2026, with major pharmaceutical and active pharmaceutical ingredient (API) markets recording moderate quarter-over-quarter declines. The downward movement was primarily associated with cautious procurement, distributor destocking, subdued spot-market activity, and sufficient availability of pharmaceutical-grade API material. Diclofenac sodium is the sodium salt of diclofenac, a widely used non-steroidal anti-inflammatory drug (NSAID). It is extensively incorporated into pharmaceutical formulations designed to manage pain and inflammation, including tablets, capsules, topical preparations, and other dosage forms. Because diclofenac sodium is an established pharmaceutical ingredient with a mature supply base, its pricing is influenced less by rapid changes in end-user consumption and more by API inventories, manufacturing costs, export competition, procurement cycles, and pharmaceutic...